IGF1R and ovarian cancer: Upregulation of IGF-IR is detected in ovarian cancer cell that acquire resistance to the p110β isoform-selective inhibitor taselisib and in PI3K-δ inhibitor idelalisib-resistant chronic lymphocytic leukemia [125, 127].